Research Article
MRI Correlates of Parkinson’s Disease Progression: A Voxel Based Morphometry Study
Table 1
Sociodemographic and clinical characteristics of the two study groups. Values denote mean (± standard deviation) or numbers of subjects.
| | PD patients | Controls |
| Sociodemographics | | | Age (years) | 60.5 (±7.7) | 64.6 (±4.8) | Sex (male/female) | 12/8 | 8/7 | Education (years) | 9.75 (±3.76) | 11.3 (±3.19) | Clinical characteristics | | | Duration of illness (years) | 5.17 (±4.14) | | Age at diagnosis (years) |
55.20 (±8.44) | | Baseline (test) OFF-drug | | | UPDRS I | 2.50 (±1.84) | | UPDRS II | 8.55 (±3.88) | | UPDRS III | 26.6 (±7.12) | | H&Y scale | 2.42 (±0.25) | | Retest OFF-drug | | | UPDRS I | 2.61 (±1.50) | | UPDRS II | 9.76 (±5.21) | | UPDRS III | 22.46 (±6.02) | | H&Y scale | 2.71 (±0.26) | | Equivalent dose of dopaminergic drug | | | Test (mg) | 473.5 (±238.0) | | Retest (mg) | 650.3 (±272.9) | |
|
|